Innovation in Central and Eastern Europe: The Life Sciences in Transition
Innogen Deputy Co-Director, Dr Peter Robbins edited a special issue of Studies in Ethics, Law and Technology with Farah Huzair, an Innogen PhD Student.
Studies in Ethics, Law and Technology Volume 2, Issue 2 (2008) Innovation in Central and Eastern Europe: The Life Sciences in Transition
This special issue explores an interdisciplinary topic that lies at the heart of Studies in Ethics, Law, and Technology. The life science industry is increasingly recognised as key sector in the growth and development of many economies. As it gains momentum, policymakers are confronted with the need to facilitate growth whilst dealing with important ethical and regulatory challenges arising from new technosciences addressing human health and the environment.
Such activities present special opportunities and threats to emerging economies such as those in Central and Eastern Europe (CEE). Countries transitioning from state-run to free market economies are confronted with the need to engage with new actors within the innovation system, such as transnational corporations and public-private partnerships while finding a place within processes of scientific and academic globalisation. At the same time science throws up new social and ethical dilemmas connected with issues such as genetic databases, drug trials and GM crops.
The special issue emerged from a workshop held in Prague in October 2007 funded by Innogen, OSI, PASOS, AstraZeneca and Medon. The workshop attempted to map a number of these dynamics within the region, and explore cases from outside of it that might inform life sciences development.